Fusion-Guided Biopsy Improves Prostate Cancer Detection

North Shore-LIJ’s prostate cancer team is the first to use the commercial version of a new prostate fusion biopsy technology, which combines magnetic resonance imaging (MRI) with real-time ultrasound for visualization of suspicious areas within the prostate gland and guidance of the biopsy needles to these “target areas.”

Get the latest health news

Keep up-to-date on breaking health news with insights from our experts and developments from around the health system.